[{"indications": "Indications\u00a0\n(From 11.3.1 Antibacterials: British National Formulary)\n11.3.1 Antibacterials", "name": "CHLORAMPHENICOL - ANTIBACTERIALS", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "11 Eye", "11.3 Anti-infective eye preparations", "11.3.1 Antibacterials", "CHLORAMPHENICOL"], "side-effects": "Side-effects\u00a0transient stinging; see also notes above", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/5376.htm", "doses": ["See Administration in\r\nnotes above"]}, {"indications": "Indications\u00a0bacterial infection in otitis externa (but \n(From 12.1.1 Otitis externa: British National Formulary)\nIf infection is present, a topical anti-infective which is not used systemically (such as neomycin or clioquinol) may be used, but for only about a week as excessive use may result in fungal infections; these may be difficult to treat and require expert advice)", "name": "CHLORAMPHENICOL ", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "12 Ear, nose, and oropharynx", "12.1 Drugs acting on the ear", "12.1.1 Otitis externa", "Anti-infective preparations", "CHLORAMPHENICOL"], "cautions": "Cautions\u00a0avoid prolonged use (\n(From 12.1.1 Otitis externa: British National Formulary)\nIf infection is present, a topical anti-infective which is not used systemically (such as neomycin or clioquinol) may be used, but for only about a week as excessive use may result in fungal infections; these may be difficult to treat and require expert advice)", "side-effects": "Side-effects\u00a0high incidence of sensitivity reactions to vehicle", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/5599.htm", "doses": ["ear, apply 2\u20133 drops 2\u20133 times daily"]}, {"indications": "Indications\u00a0see notes above", "name": "CHLORAMPHENICOL - CHLORAMPHENICOL", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "5 Infections", "5.1 Antibacterial drugs", "5.1.7 Some other antibacterials", "Chloramphenicol"], "cautions": "Cautions\u00a0avoid repeated courses and prolonged treatment; blood counts\r\nrequired before and periodically during treatment; monitor plasma-chloramphenicol concentration in\r\nneonates (see below); interactions: Appendix 1 (chloramphenicol)", "side-effects": "Side-effects\u00a0blood disorders including reversible and irreversible\r\naplastic anaemia (with reports of resulting leukaemia), peripheral\r\nneuritis, optic neuritis, headache, depression, urticaria, erythema\r\nmultiforme, nausea, vomiting, diarrhoea, stomatitis, glossitis, dry\r\nmouth; nocturnal haemoglobinuria reported; grey syndrome (abdominal\r\ndistension, pallid cyanosis, circulatory collapse) may follow excessive\r\ndoses in neonates with immature hepatic metabolism", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/3867.htm", "doses": ["By mouth or by\r\nintravenous injection or infusion, 12.5\u00a0mg/kg every 6 hours (exceptionally, can be doubled for severe\r\ninfections such as septicaemia and meningitis, providing high doses\r\nreduced as soon as clinically indicated); child over 1 month, haemophilus epiglottitis and pyogenic meningitis,\r\n12.5\u201325\u00a0mg/kg every 6 hours (high dosages decreased as soon as clinically\r\nindicated); neonate under 2 weeks,\r\n12.5\u00a0mg/kg twice daily; 2 weeks\u20131 month, 12.5\u00a0mg/kg 2\u20134 times daily", "Plasma concentration monitoring required\r\nin neonates and preferred in those under 4 years of age, in the elderly,\r\nand in hepatic impairment; recommended peak plasma concentration (approx.\r\n2 hours after administration by mouth, intravenous injection or infusion)\r\n10\u201325\u00a0mg/litre; pre-dose (\u2018trough\u2019) concentration should not exceed\r\n15\u00a0mg/litre"], "pregnancy": "Pregnancy\u00a0manufacturer advises avoid; neonatal \u2018grey syndrome\u2019\r\nif used in third trimester"}, {"indications": "Indications\u00a0\n(From 11.3.1 Antibacterials: British National Formulary)\n11.3.1 Antibacterials", "name": "CHLORAMPHENICOL Single use", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "11 Eye", "11.3 Anti-infective eye preparations", "11.3.1 Antibacterials", "CHLORAMPHENICOL", "Single use"], "side-effects": "Side-effects\u00a0transient stinging; see also notes above", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/5379.htm", "doses": ["See Administration in\r\nnotes above", "Name[Minims\u00ae Chloramphenicol (Bausch & Lomb) ] Eye drops, chloramphenicol 0.5%. Net price 20 \u00d7 0.5\u00a0mL = \u00a39.55"]}, {"indications": "Indications\u00a0see notes above", "name": "CHLORAMPHENICOL", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "5 Infections", "5.1 Antibacterial drugs", "5.1.7 Some other antibacterials", "Chloramphenicol"], "cautions": "Cautions\u00a0avoid repeated courses and prolonged treatment; blood counts\r\nrequired before and periodically during treatment; monitor plasma-chloramphenicol concentration in\r\nneonates (see below); interactions: Appendix 1 (chloramphenicol)", "side-effects": "Side-effects\u00a0blood disorders including reversible and irreversible\r\naplastic anaemia (with reports of resulting leukaemia), peripheral\r\nneuritis, optic neuritis, headache, depression, urticaria, erythema\r\nmultiforme, nausea, vomiting, diarrhoea, stomatitis, glossitis, dry\r\nmouth; nocturnal haemoglobinuria reported; grey syndrome (abdominal\r\ndistension, pallid cyanosis, circulatory collapse) may follow excessive\r\ndoses in neonates with immature hepatic metabolism", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/3867.htm", "doses": ["By mouth or by\r\nintravenous injection or infusion, 12.5\u00a0mg/kg every 6 hours (exceptionally, can be doubled for severe\r\ninfections such as septicaemia and meningitis, providing high doses\r\nreduced as soon as clinically indicated); child over 1 month, haemophilus epiglottitis and pyogenic meningitis,\r\n12.5\u201325\u00a0mg/kg every 6 hours (high dosages decreased as soon as clinically\r\nindicated); neonate under 2 weeks,\r\n12.5\u00a0mg/kg twice daily; 2 weeks\u20131 month, 12.5\u00a0mg/kg 2\u20134 times daily", "Plasma concentration monitoring required\r\nin neonates and preferred in those under 4 years of age, in the elderly,\r\nand in hepatic impairment; recommended peak plasma concentration (approx.\r\n2 hours after administration by mouth, intravenous injection or infusion)\r\n10\u201325\u00a0mg/litre; pre-dose (\u2018trough\u2019) concentration should not exceed\r\n15\u00a0mg/litre"], "pregnancy": "Pregnancy\u00a0manufacturer advises avoid; neonatal \u2018grey syndrome\u2019\r\nif used in third trimester"}]